Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant

PHASE2RecruitingINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

January 27, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions

Allogeneic Stell Cell TransplantViral Infection

Interventions

BIOLOGICAL

Viral Specific T-cells (VSTs) Scheduled

VSTs will be infused into stem cell transplant recipients on schedule.

BIOLOGICAL

Viral Specific T-cells (VSTs) Treatment

VSTs will be infused into stem cell transplant recipients only if viremia is detected.

Trial Locations (1)

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors

collaborator

Hoxworth Blood Center

OTHER

lead

Children's Hospital Medical Center, Cincinnati

OTHER